Davenport & CO LLC Nrx Pharmaceuticals, Inc. Transaction History

Davenport & CO LLC

  • $16.8 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
BUY
$4.5 - $11.91 $45,000 - $119,100
10,000 New
10,000 $48,000

Others Institutions Holding NRXP

# of Institutions
2
Shares Held
17.4K
Call Options Held
0
Put Options Held
0
View Full List

About NRX Pharmaceuticals, Inc.

NRXP Quotes by TradingView
  • Ticker NRXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,641,296
  • Market Cap $102M
  • Description
  • NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...
More about NRXP
Track This Portfolio

Track Davenport & CO LLC Portfolio

Follow Davenport & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email